Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor

Vicagrel is a new antiplatelet pro-drug based on clopidogrel sulfur lactone metabolites. The purpose of the study was to evaluate the safety, tolerability, and pharmacodynamics (PD) of vicagrel in healthy Chinese subjects. This study was designed as a single-center, randomized, double-blind, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Chen, Hanjing, Chen, Weili, Xu, Hongrong, Yuan, Fei, Yang, Mengjie, Sun, Hongbin, Yang, Jin, Liu, Yongqiang, Lai, Xiaojuan, Gong, Yanchun, Liu, Xuefang, Li, Yongguo, Sheng, Lei, Liu, Chao, Li, Xuening
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004678/
https://www.ncbi.nlm.nih.gov/pubmed/31977858
http://dx.doi.org/10.1097/MD.0000000000018683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004678/
https://www.ncbi.nlm.nih.gov/pubmed/31977858
http://dx.doi.org/10.1097/MD.0000000000018683

Ejemplares similares